Review
doi: 10.1136/gut.2005.089946.
Significance of anti-inflammatory effects of PPARgamma agonists?
Affiliations
- PMID: 16849341
- PMCID: PMC1856254
- DOI: 10.1136/gut.2005.089946
Item in Clipboard
Review
Significance of anti-inflammatory effects of PPARgamma agonists?
Gut.
2006 Aug.
Abstract
Peroxisome proliferator activated receptor γ expression in mucosal epithelial cells seems to be crucial for its anti‐inflammatory effects with respect to experimental colitis, and for maintaining homeostasis of the mucosal barrier, at least in animal models
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.Gut. 2006 Aug;55(8):1104-13. doi: 10.1136/gut.2005.081745. Epub 2006 Mar 17. Gut. 2006. PMID: 16547072 Free PMC article.
Similar articles
-
[The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)].J Soc Biol. 2006;200(2):121-31. doi: 10.1051/jbio:2006015. J Soc Biol. 2006. PMID: 17151549 Review. French.
-
PPARgamma as a new therapeutic target in inflammatory bowel diseases.Gut. 2006 Sep;55(9):1341-9. doi: 10.1136/gut.2006.093484. Gut. 2006. PMID: 16905700 Free PMC article. Review.
-
Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling.Pharmacogenet Genomics. 2009 May;19(5):363-72. doi: 10.1097/FPC.0b013e3283299a73. Pharmacogenet Genomics. 2009. PMID: 19365232
-
Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.Int Immunopharmacol. 2006 Aug;6(8):1233-42. doi: 10.1016/j.intimp.2006.02.013. Epub 2006 Apr 7. Int Immunopharmacol. 2006. PMID: 16782535
-
[Anti-inflammatory effect of PPARgamma agonists: basics and clinical applications].Nihon Rinsho. 2010 Feb;68(2):278-83. Nihon Rinsho. 2010. PMID: 20158097 Review. Japanese.
Cited by
-
Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease.Free Radic Biol Med. 2010 Feb 15;48(4):499-505. doi: 10.1016/j.freeradbiomed.2009.11.014. Epub 2009 Nov 20. Free Radic Biol Med. 2010. PMID: 19932165 Free PMC article.
-
PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages.J Cell Biol. 2007 Feb 26;176(5):681-94. doi: 10.1083/jcb.200605038. J Cell Biol. 2007. PMID: 17325208 Free PMC article.
-
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists.J Enzyme Inhib Med Chem. 2020 Dec;35(1):524-538. doi: 10.1080/14756366.2020.1713771. J Enzyme Inhib Med Chem. 2020. PMID: 31939313 Free PMC article.
-
LRG1: an emerging player in disease pathogenesis.J Biomed Sci. 2022 Jan 21;29(1):6. doi: 10.1186/s12929-022-00790-6. J Biomed Sci. 2022. PMID: 35062948 Free PMC article. Review.
References
-
- Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000405421–424. - PubMed
-
- Berger J, Moller D E. The mechanisms of action of PPARs. Annu Rev Med 200253409–435. - PubMed
-
- Escher P, Wahli W. Peroxisome proliferator‐activated receptors: insight into multiple cellular functions. Mutat Res 2000448121–138. - PubMed
-
- Michalik L, Wahli W. Peroxisome proliferator‐activated receptors: three isotypes for a multitude of functions. Curr Opin Biotechnol 199910564–570. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
